Company Profile
Hims & Hers Stock Price, News & Analysis
- Ticker:
- HIMS
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
29.66 USD (-6.29%)
Close
Last updated: August 6, 2026
6.37B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, HIMS closed down 6.29% at $29.66. No new same-company headline was identified in the current news window.
Company overview
Business overview
Hims & Hers is a consumer telehealth company delivering direct-to-consumer care across hair loss, mental health, sexual health, and other self-pay categories.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Hims sits in digital health and consumer services.
Business Model Characteristics
The business depends on subscription economics, branded consumer demand, and the ability to expand across adjacent self-pay healthcare categories.
Position Within the Biotechnology Landscape
Hims is not a biotech name, but it is a fast-growing healthcare platform whose stock reacts to customer growth and monetization.
Future catalysts
Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base. The company matters most when new categories turn into recurring subscribers rather than one-time spikes.
Recent news
- 01
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Hims & Hers (HIMS)?
Hims & Hers (HIMS) most recently closed at 29.66 USD, a -6.29% move versus the previous session.
What is the market cap of Hims & Hers (HIMS)?
Hims & Hers currently has a market capitalization of 6.37B USD on BioPharmSignal.
What does Hims & Hers do?
Hims & Hers is a consumer telehealth company delivering direct-to-consumer care across hair loss, mental health, sexual health, and other self-pay categories.
On which exchange is HIMS stock listed?
Hims & Hers (HIMS) is associated with NYSE, United States, Biopharma.
What is Hims?
Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base.
Which conditions is Hims & Hers targeting with Hims?
Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base.
How does Hims & Hers describe recent progress with Hims?
Hims & Hers's catalysts are membership growth, weight-loss and primary-care expansion, and whether the platform can keep monetizing its direct-to-consumer health base.
What is Hers?
Hims & Hers is a consumer telehealth company delivering direct-to-consumer care across hair loss, mental health, sexual health, and other self-pay categories.